Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2023-12-04 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于自愿披露公司全资子公司入选《上海市创新产品推荐目录》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the inclusion of two products from its subsidiary in the 2023 Shanghai Innovation Product Recommendation Catalog. It contains no financial statements, no discussion of financial results, no regulatory certifications, no voting results, no management changes, and no mention of any report publication. The document is short (838 characters) and is an announcement of a recognition or award related to product innovation. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial filing. It is a general regulatory announcement about product innovation recognition, which fits best under Regulatory Filings (RNS) as a miscellaneous company announcement that does not fit other categories.
2023-12-04 Chinese
科美诊断技术股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement by the company's board regarding the share repurchase plan approved on November 28, 2023, and it discloses the top ten shareholders and top ten unrestricted shareholders as of November 29, 2023. The content focuses on shareholding details related to a share buyback scheme. There is no financial statement, earnings data, or management discussion. The document is not a report but an announcement related to shareholding and share repurchase. According to the filing definitions, announcements about share repurchase or transactions in own shares fall under the category 'Transaction in Own Shares' (POS). The document length is short (2318 characters), and it contains detailed shareholding data relevant to the repurchase plan, fitting the POS category rather than a general regulatory filing or report publication announcement.
2023-12-01 Chinese
科美诊断技术股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from the board of a company regarding the progress of a share repurchase program. It details the plan to repurchase shares using company funds, the approval of the plan by the board, and the current status of the repurchase accounts and implementation. There are no financial statements or detailed financial analysis present, and the document is relatively short (1233 characters). It is not a full financial report but an update on capital activity related to share repurchases. Therefore, it fits the category of Transaction in Own Shares (POS).
2023-12-01 Chinese
科美诊断技术股份有限公司关于以集中竞价交易方式回购公司股份方案的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding a company's share repurchase plan, including the purpose, amount, price, funding source, risks, and authorization details. It discusses the company's plan to buy back shares for employee stock ownership or equity incentive plans, with specific financial figures and procedural details. The document is not a financial report like an annual or quarterly report, nor is it a simple announcement of a report publication. It is a formal disclosure about the company's transaction involving its own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2023-11-29 Chinese
科美诊断技术股份有限公司独立董事关于第二届董事会第六次会议相关事项的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent director's opinion regarding a board meeting resolution about a share repurchase plan. It discusses the legality and rationale of the company's share buyback program, including funding and impact on shareholders. There are no financial statements or detailed financial data presented, nor is this a full report or announcement of financial results. The content focuses on the share repurchase plan approval and related board matters. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back its own shares.
2023-11-29 Chinese
科美诊断技术股份有限公司第二届董事会第六次会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement from the company's board regarding the approval of a share repurchase plan via centralized bidding. It includes voting results and references a more detailed announcement on the stock exchange website. The document length is short (610 characters), and it primarily reports on a board resolution about share buyback. This fits the category of a Transaction in Own Shares (POS) filing, as it concerns the company's repurchase of its own shares. It is not a full report or financial statement, nor is it a general regulatory filing or announcement of a report publication.
2023-11-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.